These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32891948)

  • 1. Evaluation of immune efficacy of recombinant PRRSV vectored vaccine rPRRSV-E2 in piglets with maternal derived antibodies.
    Gao F; Jiang Y; Li G; Li L; Zhang Y; Yu L; Zheng H; Tong W; Zhou Y; Liu C; Shan T; Yu H; Kong N; Chen P; Tong G
    Vet Microbiol; 2020 Sep; 248():108833. PubMed ID: 32891948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV.
    Gao F; Jiang Y; Li G; Zhou Y; Yu L; Li L; Tong W; Zheng H; Zhang Y; Yu H; Shan T; Yang S; Liu H; Zhao K; Tong G
    Vaccine; 2018 May; 36(23):3269-3277. PubMed ID: 29724508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune duration of a recombinant PRRSV vaccine expressing E2 of CSFV.
    Gao F; Jiang Y; Li G; Zhang Y; Zhao K; Zhu H; Li L; Yu L; Zheng H; Zhou Y; Tong W; Tong G
    Vaccine; 2020 Nov; 38(50):7956-7962. PubMed ID: 33131934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piglets with maternally derived antibodies from sows immunized with rAdV-SFV-E2 were completely protected against lethal CSFV challenge.
    Xia SL; Du M; Lei JL; Liu Y; Wang Y; Ji S; Xiang GT; Li LF; Cong X; Luo Y; Shao L; Qiu HJ; Sun Y
    Vet Microbiol; 2016 Jul; 190():38-42. PubMed ID: 27283854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O
    Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
    BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
    Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
    Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
    Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
    Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy evaluation of three modified-live PRRS vaccines against a local strain of highly pathogenic porcine reproductive and respiratory syndrome virus.
    Huang Y; Li Z; Li J; Yibo-Kong ; Yang L; Mah CK; Liu G; Yu B; Wang K
    Vet Microbiol; 2019 Feb; 229():117-123. PubMed ID: 30642586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
    Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
    Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.